Bioengineer, Author at BIOENGINEER.ORG

Credit: Cancer Research UK Young people are less likely to try cigarettes with the printed health warning 'Smoking kills' on...

National lung cancer roundtable brings together patients, clinicians, others

December 11, 2017- The National Lung Cancer Roundtable holds its inaugural meeting on December 11-12, 2017 in Bethesda, Md., the...

New therapies improve outlook for bleeding and clotting disorders

Credit: American Society of Hematology (Atlanta, December 9, 2017) -- In three studies being presented today during the 59th American...

Using software, researchers predict tumor markers that could be immune targets

University of North Carolina Lineberger Comprehensive Cancer Center scientists have developed a software program that can accurately predict which tumor-specific...

WSU chemists develop novel Washington Red dye for bio-imaging

Credit: WSU Washington State University scientists have created an injectable dye that illuminates molecules with near infrared light, making it...

Yeast can be engineered to create protein pharmaceuticals

Credit: Mingtao Huang/Chalmers It took several years, but a research team headed by Professor Jens Nielsen at Chalmers University of...

‘Black box’ recorder puts surgeons’ robotic surgery skills under the microscope

Credit: Ricardo Carrasco III LOS ANGELES - You may know that your surgeon is using the latest minimally invasive technology...

E-cig use increases risk of beginning tobacco cigarette use in young adults

PITTSBURGH, Dec. 11, 2017 - Young adults who use electronic cigarettes are more than four times as likely to begin...

Soy, cruciferous vegetables associated with fewer common breast cancer treatment side effects

WASHINGTON -- Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard...

Low-dose treatment with Il2 across studies shows benefits in chronic graft-versus host

ATLANTA - Daily low doses of the immune signaling protein interleukin-2 (IL-2) can safely benefit patients who develop chronic graft-versus-host...

Study shows combining chemotherapy with targeted drug boosts response in chronic lymphocytic leukemia

ATLANTA - Among younger patients newly diagnosed with chronic lymphocytic leukemia (CLL), treatment with a combination of chemotherapy and a...

CAR T, immunotherapy bring new hope for multiple myeloma patients

PHILADELPHIA - Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the...

Phase 2 CAR-T study reports significant remission rates at 15-month follow up

Credit: MD Anderson Cancer Center A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows...

Global CAR T therapy trial shows high rates of durable remission for NHL

PHILADELPHIA - In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell...

Landmark CAR-T cancer study published in the New England Journal of Medicine

Credit: Loyola Medicine MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal...

Sequencing offers clues to progression toward multiple myeloma

ATLANTA -- Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma...

Rapid responses, few adverse effects in targeted agent in Phase1 trial in rare blood disorder

ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare...

Tracking how multiple myeloma evolves by sequencing DNA in the blood

ATLANTA - Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following...

Physical activity data, emojis on Apple Watch correlated with patient-reported outcomes

ATLANTA - In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of...

Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant